PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Improving immune checkpoint inhibitors’ anti-tumor response and minimizing side effects

Improving immune checkpoint inhibitors’ anti-tumor response and minimizing side effects
2023-06-01
(Press-News.org) Scientists at Tohoku University have discovered a novel approach that improves the efficacy of immune checkpoint blockade (ICB) - a novel form of cancer treatment utilizing immune checkpoint inhibitors (ICIs) - and minimizes the associated side effects. They demonstrated that using ICIs to target tumor-positive lymph nodes generates a robust anti-tumor response against both local and systemic metastases.

The study was published in the Journal of Experimental and Clinical Cancer Research on June 1, 2023.

Our immune system uses “checkpoint proteins” to regulate and control the activity of immune cells. But cancer cells can sometimes use these checkpoints to escape detection. ICB is a powerful immunotherapy that works to block these checkpoints and bolsters the immune system’s natural ability to fight cancer, rather than targeting the cancer directly.

Yet, ICB treatment’s efficacy varies from person-to-person, and it can come with some serious side effects. Medically, these are referred to as immune-related adverse events (irAEs).

The research team, which was led by Professor Tetsuya Kodama from Tohoku University’s Graduate School of Biomedical Engineering, hypothesized that metastatic lymph node-targeted ICB could improve the anti-tumor response while uncoupling it from irAEs.

The researchers tested their hypothesis by using anti-CTLA4 - a widely used ICI - on laboratory mice with lymph node and distant metastases. Their findings confirmed that delivering CTLA4 blockers directly to tumor-positive lymph nodes elicited a potent anti-tumor response against local and systemic metastases, prolonging the mice’s chance of survival.

The cancer immunotherapeutic effect was mediated by an upregulation of functionally active T cell population in the tumor-positive lymph node and spleen. In comparison, non-specific CTLA4 blockades elicited a weaker anti-tumor effect and exacerbated the side effects of using immune checkpoint inhibitors, particularly interstitial pneumonia.

“Our findings are significant because they provide a simple approach to enhancing the efficacy of ICB, whilst minimizing its associated side effects,” said Kodama. “Targeting tumor-positive lymph nodes with ICB can amplify the anti-tumor response and minimize irAEs, leading to better outcomes for cancer patients.”

Looking ahead, the team plans to further investigate lymphatic targeted approaches for improvement of therapeutic response in clinical trials to confirm its efficacy in humans.

END

[Attachments] See images for this press release:
Improving immune checkpoint inhibitors’ anti-tumor response and minimizing side effects

ELSE PRESS RELEASES FROM THIS DATE:

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

2023-06-01
Chemotherapy-induced peripheral neuropathy (CIPN) – nerve pain, tingling, or numbness in the hands or feet – is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer – the taxanes paclitaxel and docetaxel. Initial results from a large study that tracked CIPN in more than 1,100 patients treated for breast cancer with a taxane show a pattern of clinically meaningful, persistent sensory and motor symptoms, with patients experiencing more severe symptoms with paclitaxel than with docetaxel. These initial results from the SWOG S1714 clinical trial are being reported in an oral presentation at the 2023 annual ...

DOE announces $46 million for commercial fusion energy development

2023-06-01
WASHINGTON, D.C.—The U.S. Department of Energy (DOE) today announced $46 million in funding to eight companies advancing designs and research and development for fusion power plants, representing a major step in President Biden’s commitment to a pilot-scale demonstration of fusion within a decade. Fusion reactions power the stars, and research is underway to make fusion energy production on Earth possible, providing an abundant, inherently safe, non-carbon-emitting energy source for the planet. This funding from the Milestone-Based ...

More than 1 in 6 unvaccinated people report health effects of COVID two years after confirmed infection

2023-06-01
Around 1 in 6 unvaccinated individuals say they are still experiencing health effects of covid-19 up to two years after infection, finds a study from Switzerland published by The BMJ today. The findings show that 17% of participants did not return to normal health and 18% reported covid-19 related symptoms 24 months after initial infection. Most people who have covid-19 recover soon after the initial phase of the disease, but others experience persistent health problems (known as long covid), which can impact quality of life ...

Improving emergency, critical and operative care in low and middle-income countries

2023-06-01
DALLAS and GENEVA, May 31, 2023 — Global efforts to improve emergency, critical and operative care for universal health coverage and protection from health emergencies were announced at the 76th World Health Assembly in Geneva, Switzerland. With the support of its partners the American Heart Association and the Laerdal Foundation, the World Health Organization (WHO), announced an initiative based on a new acute care resolution that was approved at this year’s World Health Assembly, the decision-making body of WHO. Nearly 30 million deaths are due to emergency conditions each year, contributing to half of global deaths. The acute ...

Huntsman Cancer Institute May research highlights

Huntsman Cancer Institute May research highlights
2023-06-01
Huntsman Cancer Institute research highlights shine the spotlight on new discoveries and cutting-edge cancer research. This past month, researchers found a better treatment practice for patients who have melanoma. They also created a model for adrenocortical carcinoma, a rare cancer that originates in the outer portion of the adrenal gland. Learn more about a new brain cancer medication being fast-tracked for FDA approval and how Huntsman Cancer Institute was selected to conduct clinical trials for cancer patients with HIV. Clinical trial suggests changes to melanoma patient care A study recounting a clinical trial published ...

Postdoctoral research experience gets major boost at Pennington Biomedical

Postdoctoral research experience gets major boost at Pennington Biomedical
2023-06-01
Former Pennington Biomedical Research Center Executive Director Dr. Claude Bouchard and his wife, Monique Chagnon, were celebrated at a luncheon on Tuesday, May 30, for their generous gift to enhance the postdoctoral researcher experience at Pennington Biomedical. As one of the world’s foremost researchers in the genetics of obesity and related diseases, including type 2 diabetes and hypertension, the Bouchard laboratory has trained about 40 postdoctoral researchers throughout his career. “I became very conscious that postdocs are critical to the success of the scientific research enterprise. They work hard, they ...

New liver dialysis device shows potential to resolve liver failure in patients with acute-on-chronic liver failure

New liver dialysis device shows potential to resolve liver failure in patients with acute-on-chronic liver failure
2023-06-01
Amsterdam, June 1, 2023 – Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year. Currently the only potential treatment for this condition is liver transplantation, which is available to very few patients. A first-in-human randomized controlled clinical trial using DIALIVE, a novel liver dialysis device, demonstrated its potential as a disease-modifying therapy and resolved liver failure significantly faster and in a greater proportion of patients ...

Liver dialysis device proved safe and effective for treating severe liver failure

2023-06-01
The first successful in-patient trial of liver dialysis* has been completed by researchers from UCL, the Royal Free Hospital, UCL spin-out Yaqrit and their collaborators. The DIALIVE device, invented by researchers at UCL’s Institute for Liver and Digestive Health, was found to be safe and was associated with substantial improvement in the severity of symptoms and organ function in a greater proportion of patients with acute-on-chronic liver failure (ACLF), when compared with patients receiving standard of care. The next step will be a larger clinical trial, which if successful could see DIALIVE approved for clinical use within the next three years. Worldwide, it is estimated that there ...

Xrays reveal ancient secrets about our prehistoric world this World Dinosaur Day

2023-06-01
Researchers are shedding light on our ancient prehistoric world using state-of-the art Xray technology. This World Dinosaur Day, scientists are sharing the bones which lay beneath the Harbury Icthyosau – providing clues to dinosaur anatomy, physiology and evolution. The University's of Warwick’s Centre for Imaging, Metrology and Additive Technologies (CiMAT) group at WMG has employed its cutting-edge equipment to explore the anatomy and biology of the Harbury Icthyosaur, a large marine reptile which lived on the Earth hundreds of millions of years ...

Phototherapy device has potential to be a novel treatment for sleep complaints

Phototherapy device has potential to be a novel treatment for sleep complaints
2023-05-31
DARIEN, IL – Wearing a phototherapy device that emits near-infrared light is associated with potential therapeutic benefits for sleep and daytime functioning, according to a new study to be presented at the SLEEP 2023 annual meeting. Results show that self-reported, sleep-related symptoms improved after three weeks of treatment. Participants in the active treatment group reported experiencing better sleep quality, feeling more refreshed and relaxed, and functioning better during the day. “This novel phototherapy device — while ...

LAST 30 PRESS RELEASES:

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

Older age linked to increased complications after breast reconstruction

[Press-News.org] Improving immune checkpoint inhibitors’ anti-tumor response and minimizing side effects